Hypertension in adults across the age spectrum - Current outcomes and control in the community

被引:448
作者
Lloyd-Jones, DM
Evans, JC
Levy, D
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
[2] Blood Inst, Framingham Heart Study, Framingham, MA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 294卷 / 04期
关键词
D O I
10.1001/jama.294.4.466
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Data are sparse regarding current rates of hypertension treatment and control, and risks associated with hypertension, among persons older than 80 years. Objective To determine the prevalence of blood pressure stages, hypertension treatment and control, and cardiovascular risk among older patients with hypertension. Design, Setting, and Participants A community-based cohort study in which data were collected during all Framingham Heart Study examinations attended in the 1990s. Participants were pooled according to age: younger than 60 years, 60 to 79 years, or 80 years or older. There were 5296 participants who contributed 14458 person-examinations of observation, including 7135 hypertensive person-examinations (4919 treated). Main Outcome Measures Prevalence of hypertension, its treatment, and its control were compared across age groups. Risks for incident cardiovascular disease during follow-up of up to 6 years were estimated as multivariate-adjusted hazard ratios (HRs) and 95% confidence intervals (Cls) using Cox proportional hazards regression. Results Prevalence of hypertension and drug treatment increased with advancing age, whereas control rates were markedly lower in older women (systolic <140 and diastolic <90 mm Hg). For ages younger than 60 years, 60 to 79, and 80 years and older, respectively, control rates were 38%, 36%, and 38% in men (P=.30) and 38%, 28%, and 23% in women (P<.001). Relative risks for cardiovascular disease associated with increasing blood pressure stage did not decline with advancing age, and absolute risks increased markedly. Among participants 80 years of age or older, major cardiovascular events occurred in 9.5% of the normal blood pressure (referent) group, 19.8% of the prehypertension group (HR, 1.9; 95% Cl, 0.9-3.9), 20.3% of the stage 1 hypertension group (HR, 1.8; 95% Cl, 0.8-3.7), and 24.7% of the stage 2 or treated hypertension group (HR, 2.4; 95% Cl, 1.2-4.6). Conclusions Relative to current national guidelines, rates of blood pressure control in the community are low, especially among older Women with hypertension. Short-term risks for cardiovascular disease are substantial, indicating the need for greater efforts at safe, effective risk reduction among the oldest patients with hypertension.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 42 条
  • [21] Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials
    Gueyffier, F
    Bulpitt, C
    Boissel, JP
    Schron, E
    Ekbom, T
    Fagard, R
    Casiglia, E
    Kerlikowske, A
    Coope, J
    [J]. LANCET, 1999, 353 (9155) : 793 - 796
  • [22] Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000
    Hajjar, I
    Kotchen, TA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02): : 199 - 206
  • [23] Randomised trial of old and new antihypertensive drugs in elderly patients:: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
    Hansson, L
    Lindholm, LH
    Ekbom, T
    Dahlöf, B
    Lanke, J
    Scherstén, B
    Wester, PO
    Hedner, T
    de Faire, U
    [J]. LANCET, 1999, 354 (9192) : 1751 - 1756
  • [24] THE EPIDEMIOLOGY OF HEART-FAILURE - THE FRAMINGHAM-STUDY
    HO, KKL
    PINSKY, JL
    KANNEL, WB
    LEVY, D
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) : A6 - A13
  • [25] Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure, 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002
  • [26] INVESTIGATION OF CORONARY HEART-DISEASE IN FAMILIES - FRAMINGHAM OFFSPRING STUDY
    KANNEL, WB
    FEINLEIB, M
    MCNAMARA, PM
    GARRISON, RJ
    CASTELLI, WP
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1979, 110 (03) : 281 - 290
  • [27] Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8
  • [28] Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
    Liu, LS
    Wang, JG
    Gong, LS
    Liu, GZ
    Staessen, JA
    [J]. JOURNAL OF HYPERTENSION, 1998, 16 (12) : 1823 - 1829
  • [29] Differential control of systolic and diastolic blood pressure - Factors associated with lack of blood pressure control in the community
    Lloyd-Jones, DM
    Evans, JC
    Larson, MG
    O'Donnell, CJ
    Roccella, EJ
    Levy, D
    [J]. HYPERTENSION, 2000, 36 (04) : 594 - 599
  • [30] TRENDS IN PHARMACOLOGICAL MANAGEMENT OF HYPERTENSION IN THE UNITED-STATES
    MANOLIO, TA
    CUTLER, JA
    FURBERG, CD
    PSATY, BM
    WHELTON, PK
    APPLEGATE, WB
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (08) : 829 - 837